{"id":"W2623521568","doi":"10.1136/annrheumdis-2016-210459","title":"Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence study","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":186,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Infection and Immunity","funders":"Amgen","keywords":"Adalimumab; Medicine; Rheumatoid arthritis; Clinical endpoint; Internal medicine; Adverse effect; Bioequivalence; Pharmacokinetics; Gastroenterology; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004728189,0.0002737736,0.0008401393,0.00006441187,0.0004200886,0.00004917543,0.0007771989,0.00007733958,0.00005764285],"category_scores_gemma":[0.000289148,0.0001316971,0.0001218228,0.000161184,0.0007523947,0.000133615,0.0003698056,0.0001606603,0.000001597809],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008738381,"about_ca_system_score_gemma":0.00008863415,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001335154,"about_ca_topic_score_gemma":0.0001092484,"domain_scores_codex":[0.9980921,0.0004343373,0.0006365097,0.0003364708,0.0001734892,0.0003271017],"domain_scores_gemma":[0.9977791,0.0003032514,0.000595966,0.001053461,0.0001948661,0.00007336909],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8025352,0.01161907,0.146475,0.0003329455,0.002616544,0.000004426699,0.002239121,0.0003685211,0.000171693,0.0001987595,0.000886246,0.03255238],"study_design_scores_gemma":[0.4572364,0.001873336,0.5299529,0.004701073,0.0003077409,0.000006915646,0.0006436403,0.00006926011,0.004459323,0.0002564355,0.00004324521,0.0004497185],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946144,0.001138724,0.00003183977,0.0009839928,0.00008334414,0.002859695,0.0002108428,0.00001084654,0.00006627565],"genre_scores_gemma":[0.9993244,0.0003062895,0.00006432802,0.0001686663,0.000002382783,0.00006520579,0.000005867579,0.00001524626,0.00004758706],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3834779,"threshold_uncertainty_score":0.5370452,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04817295763684427,"score_gpt":0.3298317602822459,"score_spread":0.2816588026454016,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}